Safety of digoxin use in patients with hypertensive heart disease and atrial fibrillation

被引：0

作者：

Kahan, Thomas ^{[1
,2
]}

机构：

[1] Danderyd Hosp, Div Cardiovasc Med, Dept Clin Sci, Karolinska Inst, SE-18288 Stockholm, Sweden

[2] Danderyd Univ Hosp Corp, Dept Cardiol, SE-18288 Stockholm, Sweden

来源：

JOURNAL OF HYPERTENSION | 2015年 / 33卷 / 07期

关键词：

LEFT-VENTRICULAR HYPERTROPHY; INCREASED MORTALITY; RHYTHM CONTROL; LOSARTAN; RISK;

D O I：

10.1097/HJH.0000000000000628

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：1371 / 1372

页数：2

共 17 条

[1] Clinical Impact of Left Ventricular Hypertrophy and Implications for Regression [J].

Artham, Surya M. ;

Lavie, Carl J. ;

Milani, Richard V. ;

Patel, Dharmendrakumar A. ;

Verma, Anil ;

Ventura, Hector O. .

PROGRESS IN CARDIOVASCULAR DISEASES, 2009, 52 (02) :153-167

[2] INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY [J].

BENJAMIN, EJ ;

LEVY, D ;

VAZIRI, SM ;

DAGOSTINO, RB ;

BELANGER, AJ ;

WOLF, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11) :840-844

[3]

Butler Javed, 2010, Congest Heart Fail, V16, P191, DOI 10.1111/j.1751-7133.2010.00161.x

[4]

Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]

[5] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[6] Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart Failure [J].

Freeman, James V. ;

Yang, Jingrong ;

Sung, Sue Hee ;

Hlatky, Mark A. ;

Go, Alan S. .

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (05) :525-533

[7]

Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114

[8] Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential [J].

Kahan, T ;

Bergfeldt, L .

HEART, 2005, 91 (02) :250-256

[9] Effect of losartan on sudden cardiac death in people with diabetes:: data from the LIFE study [J].

Lindholm, LH ;

Dahlöf, B ;

Edelman, JM ;

Ibsen, H ;

Borch-Johnsen, K ;

Olsen, MH ;

Snapinn, S ;

Wachtell, K .

LANCET, 2003, 362 (9384) :619-620

[10] Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol: results from the SILVHIA study [J].

Malmqvist, K. ;

Kahan, T. ;

Edner, M. ;

Bergfeldt, L. .

JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (12) :956-965

← 1 2 →